Moreover, Kaplan-Meier analysis indicated that CRC patients with elevated expression of TM4SF1 suffered from poor survival (Fig. 1f, P < 0.01), which was consistent with the studies conducted by Sveen, Smith and Marisa in the R2 Genomic Analysis Platform (Fig. 1g-i, P < 0.01, https://hgserver1.amc.nl/cgi-bin/r2/main.cgi). The gene discussed is TM4SF1; the disease is colorectal carcinoma.